{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:14:58Z","timestamp":1761909298130,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11848-9","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:39:10Z","timestamp":1761565150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the dynamic changes in antinuclear antibody spectrum in SARS-CoV-2 infection: a retrospective analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"8","key":"11848_CR1","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity [J]. Autoimmun Rev. 2020;19(8):102597.","journal-title":"Autoimmun Rev"},{"key":"11848_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233\u20135.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"11848_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s13365-020-00858-9","volume":"26","author":"P Manganotti","year":"2020","unstructured":"Manganotti P, Pesavento V, Buoite Stella A, et al. Miller fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol. 2020;26(4):605\u20136.","journal-title":"J Neurovirol"},{"issue":"3","key":"11848_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","volume":"50","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Cao W, Jiang W, et al. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients [J]. J Thromb Thrombolysis. 2020;50(3):580\u20136.","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"11848_CR5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-1419","volume":"146","author":"HS Tsao","year":"2020","unstructured":"Tsao HS, Chason HM, Fearon DM. Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2. Pediatrics. 2020;146(2):e20201419.","journal-title":"Pediatrics"},{"issue":"18","key":"11848_CR6","first-page":"9695","volume":"24","author":"R Bonometti","year":"2020","unstructured":"Bonometti R, Sacchi MC, Stobbione P, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection [J]. Eur Rev Med Pharmacol Sci. 2020;24(18):9695\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"11848_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","volume":"10","author":"VG Jones","year":"2020","unstructured":"Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case [J]. Hosp Pediatr. 2020;10(6):537\u201340.","journal-title":"Hosp Pediatr"},{"issue":"12","key":"11848_CR8","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","volume":"79","author":"PG Vlachoyiannopoulos","year":"2020","unstructured":"Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79(12):1661\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"11848_CR9","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1007\/s10067-020-05359-y","volume":"39","author":"H Fujii","year":"2020","unstructured":"Fujii H, Tsuji T, Yuba T, et al. High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review [J]. Clin Rheumatol. 2020;39(11):3171\u20135.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"11848_CR10","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","volume":"39","author":"C Gazzaruso","year":"2020","unstructured":"Gazzaruso C, Carlo Stella N, Mariani G, et al. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin Rheumatol. 2020;39(7):2095\u20137.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"11848_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/cts.12805","volume":"13","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Han T, Chen J, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13(6):1077\u201386.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"11848_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25509-3","volume":"12","author":"SE Chang","year":"2021","unstructured":"Chang SE, Feng A, Meng W, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12(1):5417.","journal-title":"Nat Commun"},{"issue":"7866","key":"11848_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283\u20138. https:\/\/doi.org\/10.1038\/s41586-021-03631-y.","journal-title":"Nature"},{"issue":"4","key":"11848_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102792","volume":"20","author":"A Dotan","year":"2021","unstructured":"Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"11848_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-0041-1728832","volume":"48","author":"EJ Favaloro","year":"2022","unstructured":"Favaloro EJ, Henry BM, Lippi G. COVID-19 and antiphospholipid antibodies: time for a reality check? Semin Thromb Hemost. 2022;48(1):72\u201392.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"11848_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/cts.12908","volume":"14","author":"S Pascolini","year":"2021","unstructured":"Pascolini S, Vannini A, Deleonardi G, et al. COVID-19 and immunological dysregulation: can autoantibodies be useful? Clin Transl Sci. 2021;14(2):502\u20138.","journal-title":"Clin Transl Sci"},{"issue":"10","key":"11848_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218756","volume":"81","author":"A Khabbazi","year":"2022","unstructured":"Khabbazi A, Kavandi H, Paribanaem R, et al. Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic. Ann Rheum Dis. 2022;81(10):e200.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"11848_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218475","volume":"81","author":"SL Chuah","year":"2022","unstructured":"Chuah SL, Teh CL, Wan Mohd Akbar SA, Cheong YK, Sachdev Manjit Singh B. Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic. Ann Rheum Dis. 2022;81(8):e144.","journal-title":"Ann Rheum Dis"},{"key":"11848_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100091","volume":"4","author":"J-M Anaya","year":"2021","unstructured":"Anaya J-M, Monsalve DM, Rojas M, et al. Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19. J Transl Autoimmun. 2021;4:100091.","journal-title":"J Transl Autoimmun"},{"key":"11848_CR20","unstructured":"Shoenfeld Y, Blank M, Abu-Shakra M. et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008 [J]. Isr Med Assoc J. 2008;10(1): 13\u201319."},{"issue":"1","key":"11848_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-022-00923-1","volume":"7","author":"B Gong","year":"2022","unstructured":"Gong B, Huang L, He Y, et al. A genetic variant in IL-6 Lowering its expression is protective for critical patients with COVID-19. Signal Transduct Target Ther. 2022;7(1):112. Published 2022 Apr 2.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"11848_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155\u201362.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"11848_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031716","volume":"23","author":"E Gusev","year":"2022","unstructured":"Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. 2022;23(3):1716.","journal-title":"Int J Mol Sci"},{"key":"11848_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155302","volume":"137","author":"H Sat\u0131\u015f","year":"2021","unstructured":"Sat\u0131\u015f H, \u00d6zger HS, Aysert Y\u0131ld\u0131z P, et al. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19. Cytokine. 2021;137:155302.","journal-title":"Cytokine"},{"key":"11848_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijid.2020.09.1438","volume":"101","author":"M Vassallo","year":"2020","unstructured":"Vassallo M, Manni S, Pini P, et al. Patients with covid-19 exhibit different immunological profiles according to their clinical presentation. Int J Infect Dis. 2020;101:174\u20139.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"11848_CR26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/14737159.2020.1830760","volume":"20","author":"MM Azar","year":"2020","unstructured":"Azar MM, Shin JJ, Kang I, Landry M. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Expert Rev Mol Diagn. 2020;20(11):1087\u201397.","journal-title":"Expert Rev Mol Diagn"},{"key":"11848_CR27","doi-asserted-by":"publisher","first-page":"102473","DOI":"10.1016\/j.jaut.2020.102473","volume":"112","author":"Y Sun","year":"2020","unstructured":"Sun Y, Dong Y, Wang L, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: the Beijing experience. J Autoimmun. 2020;112:102473.","journal-title":"J Autoimmun"},{"issue":"12","key":"11848_CR28","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/infdis\/jiac017","volume":"225","author":"Y Acosta-Ampudia","year":"2022","unstructured":"Acosta-Ampudia Y, Monsalve DM, Rojas M, et al. Persistent autoimmune activation and proinflammatory state in post-Coronavirus disease 2019 syndrome. J Infect Dis. 2022;225(12):2155\u201362.","journal-title":"J Infect Dis"},{"issue":"1","key":"11848_CR29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00970-2022","volume":"61","author":"K Son","year":"2023","unstructured":"Son K, Jamil R, Chowdhury A, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61(1):2200970. https:\/\/doi.org\/10.1183\/13993003.00970-2022.","journal-title":"Eur Respir J"},{"issue":"12","key":"11848_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123592","volume":"10","author":"AE Gracia-Ramos","year":"2021","unstructured":"Gracia-Ramos AE, Martin-Nares E, Hern\u00e1ndez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10(12):3592. https:\/\/doi.org\/10.3390\/cells10123592.","journal-title":"Cells"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11848-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11848-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11848-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:10:29Z","timestamp":1761909029000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11848-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11848"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11848-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the Ethics Committee of Taizhou Hospital in Zhejiang Province.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1410"}}